HighTower Advisors’s Standard BioTools LAB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $269K | Buy |
224,213
+121,422
| +118% | +$146K | ﹤0.01% | 3013 |
|
2025
Q1 | $111K | Buy |
102,791
+10,000
| +11% | +$10.8K | ﹤0.01% | 3314 |
|
2024
Q4 | $162K | Buy |
92,791
+10,690
| +13% | +$18.7K | ﹤0.01% | 3226 |
|
2024
Q3 | $160K | Sell |
82,101
-6,000
| -7% | -$11.7K | ﹤0.01% | 3186 |
|
2024
Q2 | $157K | Buy |
88,101
+12,000
| +16% | +$21.4K | ﹤0.01% | 3068 |
|
2024
Q1 | $206K | Sell |
76,101
-116,569
| -61% | -$316K | ﹤0.01% | 2947 |
|
2023
Q4 | $426K | Hold |
192,670
| – | – | ﹤0.01% | 2420 |
|
2023
Q3 | $559K | Sell |
192,670
-593,616
| -75% | -$1.72M | ﹤0.01% | 2150 |
|
2023
Q2 | $1.52M | Sell |
786,286
-206,233
| -21% | -$398K | ﹤0.01% | 1511 |
|
2023
Q1 | $1.94M | Buy |
992,519
+536,341
| +118% | +$1.05M | ﹤0.01% | 1300 |
|
2022
Q4 | $534K | Buy |
456,178
+208,931
| +85% | +$245K | ﹤0.01% | 2075 |
|
2022
Q3 | $272K | Sell |
247,247
-88,824
| -26% | -$97.7K | ﹤0.01% | 2394 |
|
2022
Q2 | $538K | Buy |
336,071
+145,683
| +77% | +$233K | ﹤0.01% | 1992 |
|
2022
Q1 | $683K | Sell |
190,388
-1,242
| -0.6% | -$4.46K | ﹤0.01% | 1968 |
|
2021
Q4 | $751K | Buy |
+191,630
| New | +$751K | ﹤0.01% | 1910 |
|